Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Biochemistry, Genetics and Molecular Biology
DNA Damage
100%
Genome Instability
83%
Mitosis
77%
Polo-Like Kinase 1
74%
Cancer Cell
72%
Cell Cycle
59%
Homologous Recombination
56%
DNA Synthesis
46%
DNA Repair
44%
DNA Damage Response
40%
Kinase
36%
Phosphotransferase
36%
Poly ADP Ribose Polymerase
31%
DNA Damage Checkpoint
29%
Cyclin E1
29%
Cell Cycle Checkpoint
29%
BRCA1
28%
S Phase
27%
BRCA2
27%
Cisplatin
24%
Anaphase-Promoting Complex
23%
Cytotoxicity
22%
Gene Expression
22%
P53
18%
Epidermal Growth Factor Receptor
17%
Double-Strand DNA Break
17%
RAD51
16%
Carcinogenesis
16%
Oncogene
15%
Polo-Like Kinase
15%
Messenger RNA
14%
Chromosome Instability
14%
Transcription
14%
phosphorylation
13%
cGAS-STING
13%
Wee1
13%
Interferon
13%
Quantitative Proteomics
12%
Expression Level
12%
Downregulation
11%
Oxidative Phosphorylation
11%
MUC1
11%
Helicase
11%
Chromatin Remodeling
11%
Transcriptomics
11%
Cell Cycle Progression
11%
Genomics
11%
Tumor Suppressor Gene
10%
Cell Cycle Arrest
10%
Genetics
10%
Keyphrases
Polo-like Kinase 1
56%
DNA Damage
53%
Genomic Instability
45%
Mitosis
41%
BRCA2
38%
Homologous Recombination
38%
Cancer Cells
37%
Replication Stress
36%
PARP Inhibitors (PARPi)
34%
Tumor
32%
Inflammatory Pathways
30%
DNA Lesions
28%
RAD51
27%
Breast Cancer
26%
Anaphase-promoting Complex/cyclosome (APC/C)
23%
Cyclin E1
23%
Overexpression
22%
In Cancer
21%
DNA Damage Checkpoint
18%
CDH1
17%
CtIP
17%
Tumor Cells
17%
Cancer Treatment
16%
Triple-negative Breast Cancer
16%
DNA Repair
15%
Patient-derived Xenograft
14%
Double-strand Break
14%
DNA Double-strand Breaks
14%
CGAS-STING
14%
High-grade Serous Ovarian Cancer (HGSOC)
13%
Replication Fork Stability
13%
DNA Damage Response
13%
Ovarian Cancer
12%
Tumor Immunity
12%
Wee1 Inhibitor
12%
Cisplatin
12%
Checkpoint Kinase 1 (CHK1)
12%
Cisplatin Sensitivity
12%
Copy number Alterations
12%
Cell Cycle Checkpoint
12%
Molecular Imaging
12%
Overexpressing
12%
Aberrancy
12%
Re-resection
12%
Therapeutic Target
12%
Gene Expression
12%
Carboplatin
11%
PARylation
11%
Cytokinesis
11%
Cutaneous Melanoma
11%
